| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 4 | |
| #2 | Canada | 2 | |
| #3 | Australia | 1 | |
| #4 | China | 1 | |
| #5 | EPO (European Patent Office) | 1 | |
| #6 | Israel | 1 | |
| #7 | Republic of Korea | 1 | |
| #8 | Singapore | 1 | |
| #9 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Olive Daniel | 12 |
| #2 | Pasero Christine | 12 |
| #3 | Truneh Alemseged | 5 |
| #4 | De Gassart Aude | 4 |
| #5 | Aude De Gassart | 1 |
| #6 | Foucher Etienne | 1 |
| #7 | Cano Carla | 1 |
| #8 | Hoet René | 1 |
| #9 | Christine Pasero | 1 |
| #10 | Le Kieu Suong | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020188086A1 | Antibodies having specificity for btn2 and uses thereof | |
| WO2020136218A1 | Btn3a binding proteins and uses thereof | |
| CA3107933A1 | Anti-btn3a antibodies and their use in treating cancer or infectious disorders | |
| WO2019057933A1 | Antibodies having specificity for btn2 and uses thereof |